STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
289
13F, latest reported quarter
What the filings say about BAH
Insiders, 180 days
-$36.5K net sold
1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-01-13
Planned sales (Form 144), 90 days
$36.5K
1 notice
Booz Allen Hamilton insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Booz Allen Hamilton Holding Corp insiders sold a net $36.5K of stock across 69 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Feb 26, 2026.
The trade is 9.4% of the 4,989 shares held after it.
No other insider sold within 30 days.
289 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, PAO & Controller Metzfield Dennis sold about $36.5K of BAH on Aug 13, 2026, the largest insider sale at the company since 2024; 289 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 8.8% of the 3,990 shares held after it.
No other insider sold within 30 days.
289 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, PAO & Controller Metzfield Dennis sold about $27.5K of BAH on Feb 26, 2026, the largest insider sale at the company since 2024; 289 funds added in the latest 13F quarter.
7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on May 21, 2024.
The trade is 3.5% of the 687,745 shares held after it.
No other insider bought within 30 days.
289 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO ROZANSKI HORACIO bought about $2.0M of BAH on Oct 30, 2025, the largest insider purchase at the company on our record; 289 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BAH planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Metzfield Dennis
Filed 2026-08-13
$36.5K
BAH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Monarch Dividend Plus Index ETF
$2.1M position · as of 2026-05-31
3.5%
iShares Cybersecurity and Tech ETF
$33.9M position · as of 2026-07-31
3.3%
GMO Small Cap Quality Fund
$15.2M position · as of 2026-05-31
2.2%
DIAMOND HILL LONG SHORT FUND
$41.8M position · as of 2026-06-30
2.0%
Janus Henderson Mid Cap Growth Alpha ETF
$341.8K position · as of 2026-07-31
1.4%
Amplify Cash Flow Dividend Leaders ETF
$483.4K position · as of 2026-06-30
1.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Veterans Affairs
TRANSFORMATION TWENTY-ONE TOTAL TECHNOLOGY NEXT GENERATION (T4NG) TASK ORDER - BENEFITS INTEGRATED D · 2021-05-17
$1.4B
General Services Administration
TASK ORDER AWARD · 2022-09-06
$1.3B
Department Of Veterans Affairs
PRODUCT AND TECHNOLOGY ECOSYSTEM MANAGEMENT SERVICES (PTEMS)WHICH INCLUDES PRODUCT DELIVERY AND LIFE · 2021-01-08
$1.1B
General Services Administration
THE PURPOSE OF THIS EFFORT IS TO ACQUIRE CONTRACTOR SERVICES TO PROVIDE REAL-TIME, COMPREHENSIVE THR · 2020-06-26
$1.1B
Department Of Veterans Affairs
NEW TO - EHRM PMO IO SUPPORT · 2022-09-28
$859.7M
Department Of Veterans Affairs
IGF::OT::IGF INFORMATION TECHNOLOGY OPERATIONS AND SERVICES TRANSFORMATION SUPPORT SERVICES · 2019-05-17
$809.8M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Executive pay vs shareholder return · Horacio D. Rozanski
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$13.8M
$3.3M
$3.1M
+6%
-8%
2024
$14.0M
-$2.7M
$5.9M
+66%
+98%
2023
$15.6M
$48.2M
$3.7M
+132%
+92%
2022
$12.2M
$16.0M
$3.7M
+42%
+52%
2021
$11.9M
$9.9M
$3.1M
+32%
+81%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $36.5K sold by insiders over 180 days, 289 funds added last quarter, $36.5K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$11.0B
four quarters, 2025-10-01 to 2026-09-30
Revenue, TTM BAH
FY Mar 2026
$11.2B
FY Mar 2025
$12.0B
FY Mar 2024
$10.7B
FY Mar 2023
$9.3B
FY Mar 2022
$8.4B
Sep 2026
$2.8B
Jun 2026
$2.8B
Mar 2026
$2.8B
Dec 2025
$2.6B
Sep 2025
$2.9B
Jun 2025
$2.9B
Mar 2025
$3.0B
Dec 2024
$2.9B
At each fiscal year end
Single quarter
Net margin, TTM
+7.1%
net income over revenue, 2025-10-01 to 2026-09-30
Net margin, TTM BAH
FY Mar 2026
+7.6%
FY Mar 2025
+7.8%
FY Mar 2024
+5.7%
FY Mar 2023
+2.9%
FY Mar 2022
+5.6%
Sep 2026
+6.5%
Jun 2026
+7.1%
Mar 2026
+7.3%
Dec 2025
+7.6%
Sep 2025
+6.1%
Jun 2025
+9.3%
Mar 2025
+6.5%
Dec 2024
+6.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$984.0M
operating cash flow minus capex, 2025-10-01 to 2026-09-30
Free cash flow, TTM BAH
FY Mar 2026
$951.0M
FY Mar 2025
$911.0M
FY Mar 2024
$192.0M
FY Mar 2023
$527.0M
FY Mar 2022
$656.6M
Sep 2026
$263.0M
Jun 2026
$261.0M
Mar 2026
$212.0M
Dec 2025
$248.0M
Sep 2025
$395.0M
Jun 2025
$96.0M
Mar 2025
$194.0M
Dec 2024
$134.0M
At each fiscal year end
Single quarter
Debt to equity
3.55x
long-term 2026-09-30 plus current 2026-09-30; equity 2026-09-30
Debt to equity BAH
FY Mar 2026
3.57x
FY Mar 2025
3.99x
FY Mar 2024
3.26x
FY Mar 2023
2.83x
FY Mar 2022
2.68x
Sep 2026
3.55x
Jun 2026
3.27x
Mar 2026
3.57x
Dec 2025
3.84x
Sep 2025
3.98x
Jun 2025
3.74x
Mar 2025
3.99x
Dec 2024
2.79x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.24x
TTM operating cash flow over long-term 2026-09-30 plus current 2026-09-30
Cash flow to debt BAH
FY Mar 2026
0.26x
FY Mar 2025
0.25x
FY Mar 2024
0.08x
FY Mar 2023
0.21x
FY Mar 2022
0.26x
Sep 2026
0.24x
Jun 2026
0.31x
Mar 2026
0.26x
Dec 2025
0.26x
Sep 2025
0.23x
Jun 2025
0.27x
Mar 2025
0.25x
Dec 2024
0.28x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+70.0%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on equity BAH
FY Mar 2026
+80.7%
FY Mar 2025
+91.2%
FY Mar 2024
+59.4%
FY Mar 2023
+26.6%
FY Mar 2022
+44.1%
Sep 2026
+70.0%
Jun 2026
+68.6%
Mar 2026
+80.7%
Dec 2025
+75.1%
Sep 2025
+75.2%
Jun 2025
+96.9%
Mar 2025
+91.2%
Dec 2024
+75.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+10.1%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on assets BAH
FY Mar 2026
+11.8%
FY Mar 2025
+13.5%
FY Mar 2024
+9.2%
FY Mar 2023
+4.3%
FY Mar 2022
+8.1%
Sep 2026
+10.1%
Jun 2026
+10.5%
Mar 2026
+11.8%
Dec 2025
+12.1%
Sep 2025
+11.8%
Jun 2025
+15.1%
Mar 2025
+13.5%
Dec 2024
+13.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+18.6%
operating income after a 9.2% effective tax rate, over long-term 2026-09-30 plus current 2026-09-30 plus average of 2025-09-30 and 2026-09-30 minus cash
Return on invested capital BAH
FY Mar 2026
+24.4%
FY Mar 2025
+24.4%
FY Mar 2024
+18.2%
FY Mar 2023
+10.0%
FY Mar 2022
+17.6%
Sep 2026
+18.6%
Jun 2026
+20.6%
Mar 2026
+24.4%
Dec 2025
+22.7%
Sep 2025
+22.2%
Jun 2025
+25.7%
Mar 2025
+24.4%
Dec 2024
+24.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+17.5%
operating income (EBIT proxy) over average of 2025-09-30 and 2026-09-30 minus current liabilities
Return on capital employed BAH
FY Mar 2026
+18.9%
FY Mar 2025
+26.5%
FY Mar 2024
+21.3%
FY Mar 2023
+9.8%
FY Mar 2022
+15.8%
Sep 2026
+17.5%
Jun 2026
+19.0%
Mar 2026
+18.9%
Dec 2025
+20.2%
Sep 2025
+21.4%
Jun 2025
+26.6%
Mar 2025
+26.5%
Dec 2024
+27.5%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.95x
close 2026-10-27 over four quarters of diluted EPS, 2025-10-01 to 2026-09-30
P/E, trailing BAH
FY Mar 2026
11.33x
FY Mar 2025
14.42x
FY Mar 2024
32.34x
FY Mar 2023
45.66x
FY Mar 2022
25.53x
Sep 2026
10.78x
Jun 2026
9.54x
Mar 2026
11.33x
Dec 2025
12.53x
Sep 2025
15.26x
Jun 2025
12.79x
Mar 2025
14.42x
Dec 2024
19.21x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$14.0B
market value at close 2026-10-27 on 2026-10-19 shares, plus long-term 2026-09-30 plus current 2026-09-30, minus cash 2026-09-30
Enterprise value BAH
FY Mar 2026
$12.6B
FY Mar 2025
$16.4B
FY Mar 2024
$22.1B
FY Mar 2023
$14.7B
FY Mar 2022
$13.8B
Sep 2026
$12.4B
Jun 2026
$10.7B
Mar 2026
$12.6B
Dec 2025
$13.3B
Sep 2025
$15.5B
Jun 2025
$16.2B
Mar 2025
$16.4B
Dec 2024
$19.4B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.9%
TTM free cash flow over market value at close 2026-10-27
FCF yield BAH
FY Mar 2026
+10.1%
FY Mar 2025
+6.9%
FY Mar 2024
+1.0%
FY Mar 2023
+4.3%
FY Mar 2022
+5.6%
Sep 2026
+11.8%
Jun 2026
+15.4%
Mar 2026
+10.1%
Dec 2025
+9.1%
Sep 2025
+6.6%
Jun 2025
+7.6%
Mar 2025
+6.9%
Dec 2024
+5.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -2%, PEG needs growth
PEG, trailing BAH
FY Mar 2026
n/a
FY Mar 2025
0.25x
FY Mar 2024
0.26x
FY Mar 2023
n/a
FY Mar 2022
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
27.99x
Sep 2025
5.11x
Jun 2025
0.17x
Mar 2025
0.25x
Dec 2024
0.17x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BAH ranks highest on institutional and government (90th percentile) and profitability (80th), and lowest on financial health (30th), among Services peers.
Profitability
80
Inputs
Return on equity+70.0% · 96 pct, sector of 207
Return on assets+10.1% · 84 pct, sector of 269
Return on invested capital+18.6% · 62 pct, sector of 81
Return on capital employed+17.5% · 78 pct, sector of 203
Financial health
30
Inputs
Debt to equity3.55x · 7 pct, sector of 228
Cash flow to debt0.24x · 53 pct, sector of 199
Growth
34
Inputs
Revenue growth, YoY-6.4% · 24 pct, sector of 341
Backlog growth, YoY-2.5% · 45 pct, sector of 77
Insider conviction
34
Inputs
Net Form 4 buying (codes P and S), 180d-$37K · 67 pct, sector of 174
Insider buyers, 180d0 · 0 pct, sector of 179
Institutional and government
90
Inputs
Funds adding, latest quarter289 · 86 pct, sector of 243
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180d$579.0M · 91 pct, universe of 69
Lobbying spend, 4 quarters$4.4M · 92 pct, sector of 61
Risk and compliance
38
Inputs
Short interest, % of float+5.9% · 31 pct, sector of 383
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+13.2% · 46 pct, sector of 227
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BAH filings, in plain words
Are Booz Allen Hamilton insiders buying or selling BAH?
In the 180 days to 2026-10-28, Booz Allen Hamilton insiders were net sellers, a net $36.5K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded BAH?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Rob Bresnahan dated 2025-01-13.
Are there planned insider sales of BAH?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $36.5K of stock; the latest, by Metzfield Dennis, was filed 2026-08-13.
Read the full summary
In the 180 days to 2026-10-28, Booz Allen Hamilton insiders were net sellers of BAH, a net $36.5K across purchases and sales reported on Form 4 by 1 seller. Members of Congress have disclosed trades in BAH, none in the last year; the latest on record is a sale by Rob Bresnahan dated 2025-01-13. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $36.5K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.